Amprius Technologies Inc (NYSE:AMPX)

Q1 2025 Amprius Technologies Inc Earnings Call Transcript

May 8, 2025 / 09:00 PM GMT

Release Date Price: $2.49 (+5.51%)

Transcript 10-Q8-K

Key Points

Positve

Amprius Technologies Inc (AMPX) reported a significant revenue increase of 383% year-over-year, reaching $11.3 million in Q1 2025.
The company shipped products to 102 customers, with 46 being new, indicating strong market penetration and customer acquisition.
Amprius Technologies Inc (AMPX) introduced new high-performance battery products, including a 370 watt per kg high-power pouch cell and a 6,300 mAh cylindrical cell, which have attracted significant market interest.
The company has a strong global presence, with 83% of its revenue coming from outside the United States, reducing exposure to domestic tariff issues.
Amprius Technologies Inc (AMPX) maintains a strong financial position with $48.4 million in net cash and no debt, providing flexibility for future growth initiatives.

Negative

The company reported a GAAP net loss of $9.4 million for the first quarter, indicating ongoing profitability challenges.
Operating expenses increased by 24% year-over-year, driven by investments in sales and R&D, which could pressure margins if revenue growth does not keep pace.
Amprius Technologies Inc (AMPX) faces potential risks from new product introductions potentially cannibalizing existing offerings.
The company is still in the process of scaling its manufacturing capabilities, which may delay meeting increasing demand.
There is uncertainty regarding the timing and availability of funding for future projects, such as the Colorado facility, which could impact long-term growth plans.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMPX.N - Amprius Technologies Inc
Q1 2025 Amprius Technologies Inc Earnings Call
May 08, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. Welcome to the Embryo Technologies first quarter 2025 earnings conference call. Joining us for today's presentation are the company CEO, Dr. Tang Sun and CFO Sandra Wallach. At this time, all participants are in listen-only mode. Following Manja's remarks, we will open the call for questions. Please note that this presentation contains forward-looking statements, including but not limited to statements regarding our financial and business performance, our business strategy, future product development or commercialization. New customer adoption and new applications, our growth and the growth of the markets in which we operate and the timing and ability of Ambrus to expand its manufacturing capacity, scale business

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.